Atlas Trials

NextCure, Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch NextCure, Inc.

RecordFirmDate
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors (NCT06792552)NextCure, Inc.2025-02-26
A Phase 1 Study of LNCB74 in Advanced Solid Tumors (NCT06774963)NextCure, Inc.2025-01-07
A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms (NCT05787496)NextCure, Inc.2023-02-28
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors (NCT05572684)NextCure, Inc.2022-10-06
A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC (NCT04430933)NextCure, Inc.2021-12-06
A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors (NCT04875806)NextCure, Inc.2021-06-30
A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors (NCT04408599)NextCure, Inc.2020-06-10
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors (NCT03665285)NextCure, Inc.2018-10-01

Track NextCure, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.